Former White House press secretary Karine Jean‑Pierre arrived on Capitol Hill Friday to testify before the House Oversight Committee as lawmakers pursue allegations of a cover‑up of President Joe Biden’s cognitive decline and scrutiny over the administration’s use of the presidential autopen to sign clemency documents.
Oversight Committee Chairman James Comer, R‑Ky., said investigators intentionally scheduled Jean‑Pierre near the end of a sequence of interviews because of material she disclosed in a forthcoming book about her time in the Biden White House. Comer said he planned to question her about passages he said would be “of interest” to the panel’s inquiry, including references to former vice president Kamala Harris’ forthcoming memoir and details related to last‑minute pardons and commutations signed as the administration left office.
Jean‑Pierre, who has left the Democratic Party and is writing a book described by Comer as a tell‑all about a “broken” administration, declined to answer questions from reporters as she entered the hearing. During her tenure in the White House, she repeatedly defended Mr. Biden against questions about his age and mental acuity, telling reporters in February 2024 that “He passes a cognitive test every day,” and characterizing social‑media clips of the president’s gaffes and missteps as misleading.
Lawmakers said their investigation includes several strands: whether White House officials concealed concerns about the president’s cognitive abilities, assertions in Harris’ book that it was “reckless” for Biden to seek a second term, and newly disclosed emails that they say show inconsistent processes surrounding the use of the autopen to affix the president’s signature. Some of those emails, first reported by the New York Post, purportedly show autopen signatures placed on thousands of clemency documents, including commutations and pardons, in the hours before the administration left the White House.
Comer told reporters the messages indicate a process “in direct conflict with the Merrick Garland Department of Justice,” adding that there were inconsistencies between depositions and the email record about how the autopen was used. The committee has sought to determine whether some clemency actions were finalized without the same level of review or approval that the Justice Department typically applies.
The panel previously pressed Biden’s personal physician, Dr. Kevin O’Connor, who invoked the Fifth Amendment in July during a deposition before the committee. O’Connor has not taken substantive questions from reporters about the president’s health beyond releasing brief written summaries of annual physicals. Those summaries did not include formal neurocognitive testing, and the committee noted Mr. Biden did not undergo a Montreal Cognitive Assessment, a short screening used to detect signs of cognitive impairment.
Days before the president abandoned his 2024 re‑election bid, O’Connor told a media outlet that the president’s mental fitness was “excellent.” The committee’s focus on clinical assessments is part of its effort to establish what officials knew, and when, about the president’s condition.
Former colleagues and internal messages have also drawn scrutiny. Some former White House staffers told media outlets that Andrew Bates, a fellow spokesman, was deployed by Jean‑Pierre in the final months of the administration to rebut or attack journalists probing a White House publicist who later became a subject of controversy. Those accounts emerged after Jean‑Pierre and others left the administration.
In addition to questions about cognitive fitness and internal communications, the Justice Department’s role in the clemency process has been a central line of inquiry. Republicans on the committee have argued that some autopen use circumvented established DOJ procedures; committee members say they are examining evidence to determine whether the Justice Department’s usual vetting of clemency requests occurred.
Jean‑Pierre’s appearance follows a series of public and closed‑door interviews the committee has conducted with current and former administration officials. The Oversight Committee has not concluded its work, and members from both parties have disputed characterizations of the effort, with Democrats calling the investigation politically motivated and Republicans saying they are following documents and testimony.
The testimony also arrives amid heightened public attention to how information about a president’s health is vetted and disclosed. The White House has long released doctors’ statements in lieu of extended public medical examinations, and the committee’s inquiry highlights the tension between executive privacy, public interest in a president’s fitness for office, and congressional oversight responsibilities.
As Jean‑Pierre took her seat with committee staff, members prepared to question her about the administration’s handling of communications related to the president, the sequence of approvals for late‑term clemency decisions and what contemporaneous officials knew about the president’s mental condition. The Oversight Committee provided no immediate timetable for further public hearings or for releasing any related documents that may arise from Friday’s session.
